Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Low RiskFDA Drug
Medications & Supplements/Prescription Drugs

McKesson Corporation dba McKesson Drug Company: Levetiracetam Tablets Recalled Due to Barcode Error and Potential Mislabeled Drug

Agency Publication Date: June 9, 2021
Share:
Sign in to monitor this recall

Summary

McKesson Corporation is recalling 210 cartons of Levetiracetam Tablets USP, 250 mg (100-count unit dose boxes) because of a barcode error on the packaging. While the human-readable text on the box correctly identifies the medicine as Levetiracetam, the machine-readable barcode could incorrectly scan as Naproxen Tablets 500 mg. This recall affects one specific lot distributed nationwide across the United States.

Risk

If the barcode scans incorrectly, a patient could potentially receive the wrong medication (Naproxen instead of Levetiracetam) at a pharmacy or hospital. Receiving the wrong medication can lead to untreated medical conditions or adverse reactions to an unintended drug.

What You Should Do

  1. Check your medication packaging for Levetiracetam Tablets USP, 250 mg (10x10 unit dose boxes) with NDC 63739-795-10.
  2. Verify if your product matches Lot Number 0000124916 with an expiration date of 09/30/2022.
  3. Immediately contact your healthcare provider or pharmacist if you believe you have received the incorrect medication or have questions about your prescription.
  4. Contact McKesson Corporation or the pharmacy where you purchased the medication to arrange for the return of any unused product for a refund.
  5. For additional questions or to report a problem, contact the FDA Consumer Complaint hotline at 1-888-723-3332 or visit www.fda.gov/safety/recalls.

Your Remedy Options

💰Full Refund

Return for refund and pharmacist consultation.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Levetiracetam Tablets USP, 250 mg UD 100 Tablets (10x10) boxes
Model:
NDC 63739-795-10
Recall #: D-0630-2021
Lot Numbers:
0000124916 (Exp. 09/30/2022)
Date Ranges: Expiration date 09/30/2022

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 88008
Status: Resolved
Manufacturer: McKesson Corporation dba McKesson Drug Company
Sold By: McKesson Drug Company; pharmacies
Manufactured In: United States, India
Units Affected: 210 cartons
Distributed To: Nationwide
Agency Last Updated: June 15, 2021

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.